Development of anti-tumor immunity following thymidine kinase-mediated killing of experimental brain tumors.
Using the 9L experimental brain tumor model, we studied long-term tumor regression and immunologic consequences of tumor killing in a model of in vivo gene transfer of the herpes simplex virus 1 thymidine kinase (HSV-TK) gene and ganciclovir (GCV) treatments. Fibroblasts modified to produce retrovir...
Sparad:
| I publikationen: | Proc Natl Acad Sci U S A |
|---|---|
| Huvudupphov: | , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Utgiven: |
National Academy of Sciences
1994
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC43782/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8183911/ https://ncbi.nlm.nih.govhttps://doi.org/10.1073/pnas.91.10.4348 |
| Taggar: |
Inga taggar, Lägg till första taggen!
|